secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYPHERPUNK TECHNOLOGIES INC. (CYPH)
CIK:        0001509745
Form:       8-K/A
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001104659-23-036607
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Leap Therapeutics removes requirement to file Flame Biosciences financials
--------------------------------------------------------------------------

- Amendment to 8-K (filed Jan 23, 2023) deletes references to filing financial statements and pro forma info for Flame Biosciences acquisition.
- Company determined financial statements for the January 2023 acquisition are not required under Item 9.01 of Form 8-K.
- No change to acquisition terms or closing date; procedural update only.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509745/000110465923036607/0001104659-23-036607-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509745/000110465923036607/tm2310372d2_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-036607

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer